From a new trial in Canada looking at therapeutics to help prevent severe symptoms of COVID-19 in patients with cancer to updated guidelines from the American Cancer Society on taking the HPV vaccine to prevent certain cancers, here’s what’s making the headlines in the cancer space this week.
“Let's try to make something good out of something really bad,” says “Survivor: Africa” winner, and lymphoma survivor, Ethan Zohn.
The Food and Drug Administration has had a busy couple of weeks, approving new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.
The Food and Drug Administration granted accelerated approval to Xpovio for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma who have undergone two prior therapies.
Dr. Caron A. Jacobson discusses the potential long-term impact of Yescarta for patients with relapsed or refractory indolent non-Hodgkin lymphoma and how it could turn an incurable disease into something curable.
“Survivor: Africa” winner Ethan Zohn details his journey with cancer and discovering that it isn’t a sprint, but a marathon.
Data presented at the ASCO 2020 Virtual Scientific Program demonstrated that Keytruda was an effective treatment for patients with Hodgkin Lymphoma and side effects were tolerable.
Being a young adult with cancer can feel like an isolating journey, but "Survivor: Africa" winner Ethan Zohn details how a community can form even in the unlikeliest of places.
In an interview with CURE, “Survivor: Africa” winner Ethan Zohn talks about how his cancer journey changed his perspective on life and helps him to navigate the COVID-19 pandemic.
On this week’s episode of the “CURE Talks Cancer” podcast, we spoke with “Survivor: Africa” winner Ethan Zohn on his journey with cancer and advocating for lymphoma awareness.
The allogeneic “off-the-shelf” CAR-T cell therapy ALLO-501, paired with the monoclonal antibody ALLO-647, demonstrated clinical responses and a manageable safety profile in patients with pretreated large B-cell and follicular lymphomas.
Former Survivor competitor, and winner, Ethan Zohn talks with CURE about his journey with cancer and raising awareness for patients with leukemia and lymphoma.
A diffuse large B-cell lymphoma survivor shares her frank and funny view of coping with cancer.
One survivor has advice for others affected by both cancer and the COVID-19 pandemic: Accept your limitations.
Dealing with the challenges of health and wellness after cancer treatment is tricky enough, but managing it in the midst of the COVID-19 pandemic is an even bigger obstacle. One survivor details how she tries to take it one wellness win at a time.
One survivor describes her journey with breast implant associated anaplastic large cell lymphoma, and how she advocates for more awareness to protect future patients.
Dr. Wendy S. Harpham’s e-book “Finding Hope That Heals” looks to help patients with cancer craft, and achieve, attainable goals on their cancer journey.
From a 105-year-old cancer survivor recovering from COVID-19 to a 7-year-old finishing his last chemotherapy treatment for lymphoma and also beating COVID-19, here’s what’s making the headlines in the cancer landscape this week.
One survivor leans on their experiences from fighting cancer to find the strength to pivot during the time of the COVID-19 pandemic.
With breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) making recent headlines, many questions remain about this newly discovered illness.
From the Food and Drug Administration’s new clinical trial guidelines amid the COVID-19 pandemic to a mother meeting the cancer survivor who received her son’s heart 20 years after his passing, here’s what is making headlines in the cancer space this week.
Patients with relapsed and resistant diffuse large B-cell lymphoma can look to new treatments beyond tried-and-true chemotherapy.
ESPN sports reporter Edward Aschoff died because of undetected stage 4 non-Hodgkin's lymphoma— cancer detection methods need to change.
